Framework/March 2026, 12 min

A buyer-side scorecard for HCP measurement claims.

Measurement claims need a buyer-side scorecard because surface-level dashboards can hide methodological gaps, audience overlap, and weak governance.

Question one: What exactly is being measured?

HCP reach, NPI exposure, script movement, audience quality, engagement, and incremental impact are different claims. A partner should be explicit about which claim it is making and which claim it is not making.

Question two: What is the comparison standard?

Every measurement claim depends on a comparison: exposed versus unexposed, target versus control, before versus after, channel versus channel. The comparison standard should be clear enough for a brand team to explain without the vendor in the room.

Question three: Can the method be reconciled?

A measurement system becomes more valuable when it can be reconciled with other sources. If a dashboard cannot be mapped back to audience definitions, vendor delivery, and campaign decisions, it is insight theater rather than governance.

Question four: What would change the plan?

Measurement should influence decisions. Before launch, the team should define which signal will trigger reallocation, a vendor escalation, a channel shift, or a deeper diagnostic.

Apply this to your launch

Turn the note into an operating standard.

Cadence helps pharma and biotech teams translate these governance questions into a practical launch plan, vendor diligence process, and measurement record.

Schedule Advisory Call